


Employees at Biogen rank Michel Vounatsos in the Bottom 35% of CEOs in Boston. Comparatively, employees at IPSEN rank David Loew in the Top 35% of CEOs in Boston. Employees rate their CEO differently based on the frequency of interaction, ability to affect company culture, and drive measurable results.

CEO of Biogen
BIO: Mr. Michel Vounatsos has been the Chief Executive Officer of Biogen Inc. since January 6, 2017. Mr. Vounatsos served as the Chief Commercial Officer and Executive Vice President of Biogen Inc. since April 18, 2016 until December 2016. He is a sophisticated global business leader who has a track record of commercial success and creativity. He joined Biogen after a 20 year career at Merck, where he various positions including served as president, Primary Care Business Line and Merck Customer Centricity. Prior to this role, he held leadership positions at Merck across Europe and in China. He has been Director of Biogen Inc. since January 6, 2017. Mr. Vounatsos attended the Universite Victor Segalen, Bordeaux II, in France, receiving his C.S.C.T. certificate in Medicine. He received his M.B.A. from the HEC School of Management in Paris.

CEO of IPSEN
BIO: David has over 25 years of experience in the pharmaceutical industry where he has held various global executive positions in major pharmaceutical and biotechnology companies. Prior to joining Ipsen David was Executive Vice-President and President of the oncology division of Baxalta. David started his biopharma career at Johnson & Johnson and Janssen Pharmaceutica (1989-2004) where he held a variety of senior US sales and marketing positions across therapeutic areas in primary care, specialty care, and oncology. He then joined Novartis (2005-2012), where he successively served as the global business franchise head for the company’s respiratory and dermatology franchise in Basel, Switzerland; President and Chief Executive Officer of the pharmaceutical division in Canada; and the head of oncology for Northern, Central and Eastern Europe. From 2012 to 2014, he served as Chief Commercial Officer of Endocyte, an oncology biotechnology company. Prior to his biopharma career David was an officer in the United States Army. He is a graduate of the University of Cincinnati. David serves on the Boards of uniQure, PhRMA, EFPIA and Camping and Education Foundation.

Women at Biogen rated their CEO a B-

Not Enough Data

Diverse Employees at Biogen rated their CEO a B-

Not Enough Data


Not Enough Data


Not Enough Data
At Biogen, employees in the HR department rate Michel Vounatsos the highest. According to employees, Michel Vounatsos' ability to drive business results is Very Bad.